Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision (Revision: v3.4.2) was added and an older funding-status notice along with Revision: v3.4.1 were removed; these changes are administrative and do not affect the study details or content.SummaryDifference0.4%

- Check21 days agoChange DetectedA new notice about a lapse in government funding was added and the site version updated to v3.4.1; the previous version reference v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page adds a glossary toggle and updates metadata labels, including a new 'Last Update Submitted that Met QC Criteria' entry and a new 'Revision: v3.4.0' tag, with adjusted capitalization for 'No FEAR Act' data. These changes are UI/metadata improvements and do not alter core study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a centralized Locations section listing study sites in CA, FL, GA, OR, TX, and VA. Removed individual state Location sections (CA Locations, FL Locations, GA Locations, OR Locations, TX Locations, VA Locations); revision updated to v3.3.3.SummaryDifference0.6%

- Check85 days agoChange DetectedFooter revision label updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.